These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16710907)

  • 1. Cetuximab plus radiotherapy for head and neck cancer.
    Armstrong JG
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
    [No Abstract]   [Full Text] [Related]  

  • 2. Cetuximab plus radiotherapy for head and neck cancer.
    Cengiz M; Yildiz F; Genc M
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
    Teoh DC; Rodger S; Say J; Hartley A
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
    [No Abstract]   [Full Text] [Related]  

  • 4. Cetuximab plus radiotherapy for head and neck cancer.
    Ho AC
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
    Chan A; Teoh D; Sanghera P; Hartley A
    Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetuximab and radiotherapy for head and neck cancer.
    Posner MR; Wirth LJ
    N Engl J Med; 2006 Feb; 354(6):634-6. PubMed ID: 16467552
    [No Abstract]   [Full Text] [Related]  

  • 7. Cetuximab plus radiotherapy for head and neck cancer.
    Hartig F; Pechlaner C
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
    [No Abstract]   [Full Text] [Related]  

  • 8. More on cetuximab in head and neck cancer.
    Mell LK; Weichselbaum RR
    N Engl J Med; 2007 Nov; 357(21):2201-2; author reply 2202-3. PubMed ID: 18032774
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
    Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
    N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
    Bonner JA; Harari PM; Giralt J; Cohen RB; Jones CU; Sur RK; Raben D; Baselga J; Spencer SA; Zhu J; Youssoufian H; Rowinsky EK; Ang KK
    Lancet Oncol; 2010 Jan; 11(1):21-8. PubMed ID: 19897418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab in squamous cell head and neck carcinomas.
    Gebbia V; Giuliani F; Valori VM; Agueli R; Colucci G; Maiello E
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi5-7. PubMed ID: 17591832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are anti-vitamin K drugs contraindicated with cetuximab during head-and-neck cancer concomitant radiotherapy?
    Brohée D; Henry AR; Castadot P
    Acta Clin Belg; 2013; 68(3):237-9. PubMed ID: 24156231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.
    Wieczorek A; Hamid A; O'Toole L
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):496. PubMed ID: 21482459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases].
    Xia LP; Zhang B; Liu MZ; Hu PL; Chen XX; Guo GF; Qiu HJ; Rong YM; Qian SY; Zhou FF; Huang YY; Wang TL
    Ai Zheng; 2009 Sep; 28(9):977-82. PubMed ID: 19728918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acneiform rash secondary to cetuximab plus head and neck radiotherapy.
    Mydin AR; Armstrong JG
    Radiother Oncol; 2007 Oct; 85(1):171. PubMed ID: 17531339
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of advanced head and neck cancer with cetuximab.
    Merlano M; Garrone O
    Int J Biol Markers; 2007; 22(1 Suppl 4):S71-6. PubMed ID: 17520584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oncological treatment modalities in head and neck cancer].
    Saarilahti K; Lindholm P
    Duodecim; 2011; 127(18):1979-85. PubMed ID: 22034736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab-induced pneumonitis in head and neck cancer patient.
    De Vos FY; Driessen CM; Jaspers HC; van Herpen CM; Simons B
    Oral Oncol; 2012 Jun; 48(6):e17-8. PubMed ID: 22342570
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.
    Chan AL; Leung HW; Huang SF
    Clin Drug Investig; 2011 Oct; 31(10):717-26. PubMed ID: 21744880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):79-81. PubMed ID: 17344795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.